| scholarly article | Q13442814 |
| P2093 | author name string | Siegfried Hoyer | |
| P2860 | cites work | Cell damage in the brain: a speculative synthesis | Q34253066 |
| ATP and brain function | Q38597443 | ||
| Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia | Q39856970 | ||
| Role of Ca2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes | Q42849346 | ||
| Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in thein vitroguinea-pig hippocampus | Q46397145 | ||
| Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease | Q48483328 | ||
| Alzheimer's disease: focal cortical changes shown by positron emission tomography | Q48768559 | ||
| Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation | Q48922050 | ||
| In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. | Q53189485 | ||
| Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease | Q53192901 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 207-224 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Molecular and Chemical Neuropathology | Q27709442 |
| P1476 | title | Oxidative energy metabolism in Alzheimer brain | |
| P478 | volume | 16 |
| Q53207764 | Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. |
| Q47990556 | Additional mechanisms for brain activation failure due to reduced glucose metabolism-a commentary on Zilberter and Zilberter: The vicious circle of hypometabolism in neurodegenerative diseases |
| Q73225259 | Age-related alteration of intracellular ATP maintenance in the cell suspensions of mice cerebral cortex |
| Q40450162 | Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. |
| Q34571929 | Alois Alzheimer revisited: differences in origin of the disease carrying his name |
| Q36634036 | Alzheimer disease--no target for statin treatment. A mini review |
| Q39398227 | Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration. |
| Q53379775 | Amyloid-β peptide absence in short term effects on kinase activity of energy metabolism in mice hippocampus and cerebral cortex. |
| Q36846711 | Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease |
| Q34997783 | Brain aging and Alzheimer's disease; use it or lose it. |
| Q34102952 | Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update |
| Q38283992 | Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology |
| Q40930592 | Breakdown of membrane phospholipids in Alzheimer disease. Involvement of excitatory amino acid receptors |
| Q37075513 | Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease |
| Q61709806 | Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ |
| Q48165497 | Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis |
| Q73052709 | Effect of adrenalectomy and corticosterone substitution on glucose and glycogen metabolism in rat brain |
| Q44880809 | Effects of beta-hydroxybutyrate on cognition in memory-impaired adults |
| Q44476906 | Effects of lactate/pyruvate on synaptic plasticity in the hippocampal dentate gyrus |
| Q33702630 | Effects of medicinal plants on Alzheimer's disease and memory deficits. |
| Q47937645 | Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers |
| Q36629895 | From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain |
| Q37269722 | Genetic and nongenetic variation revealed for the principal components of human gene expression |
| Q39012005 | Glucose Transporters in Brain: In Health and in Alzheimer's Disease |
| Q38950480 | In vitro streptozotocin model for modeling Alzheimer-like changes: effect on amyloid precursor protein secretases and glycogen synthase kinase-3. |
| Q53314155 | Increased CSF pyruvate levels as a marker of impaired energy metabolism in Alzheimer's disease. |
| Q46914423 | Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. |
| Q46446421 | Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin |
| Q36938165 | Modeling Alzheimer's disease: from past to future |
| Q36796902 | Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons |
| Q53213229 | Neural membrane phospholipids in Alzheimer disease. |
| Q33581218 | Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease |
| Q53340967 | Oxidative modification of creatine kinase BB in Alzheimer's disease brain. |
| Q39112076 | Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a |
| Q33460503 | Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease |
| Q36076365 | Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment |
| Q21245063 | Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial |
| Q48858640 | Tau binds ATP and induces its aggregation |
| Q38064315 | The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease |
| Q38809233 | The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction |
| Q28544995 | Using bioconductor package BiGGR for metabolic flux estimation based on gene expression changes in brain |
Search more.